; and (ii) at the discretion of the Secretary, for each type of applicable non-retail pharmacy (as identified pursuant to the type indicators established by the Secretary under subsection (k)(12)(B)(ii)), the determination of survey prices, separate from the survey prices described in paragraph (1)(A)(i) or clause (i) of this subparagraph, of the national average drug acquisition cost for such type of pharmacy for covered outpatient drugs that represent a nationwide average of consumer purchase prices for such drugs, net of all discounts and rebates (to the extent any information with respect to such discounts and rebates is available) based on a monthly survey of such pharmacies. (B) Application of requirements Subparagraphs (C), (D), and (E) of paragraph (1) shall apply to surveys of non-retail pharmacy drug prices conducted under this paragraph in the same manner as such subparagraphs apply to surveys of retail pharmacy drug prices conducted under subparagraph (1). (C) Additional requirement In addition to the terms and conditions identified in paragraph (1)(D), and such other terms and conditions as the Secretary shall specify, a contract with a vendor under this paragraph shall require that the vendor must differentiate, in collecting and reporting survey data, the relevant pharmacy type indicator for all cost information collected, including whether a pharmacy is owned by, operated by, or otherwise affiliated with a pharmacy benefit manager and whether a pharmacy is an applicable non-retail pharmacy, and, in the case of an applicable non-retail pharmacy, which type of applicable non-retail pharmacy (as identified pursuant to the type indicators established by the Secretary under subsection (k)(12)(B)(ii)) it is. (D) Survey reporting In order to meet the requirement of section 1902(a)(54), a State shall require that any applicable non-retail pharmacy in the State that receives any payment, reimbursement, administrative fee, discount, or rebate related to the dispensing of covered outpatient drugs to